Author

Christopher Hillis

Observed names: C Hillis, C. Hillis, C. M. Hillis, C.M. Hillis, Chris Hillis, Christopher M Hillis, Christopher M. Hillis, Christopher Michael Hillis, Hillis, Christopher, Hillis,Christopher

Institution: McMaster University

Observed institutions: Western University, St. Michael's Hospital, Sunnybrook Health Science Centre, University Health Network, University of Toronto, Juravinski Cancer Centre, Juravinski Hospital, Hamilton Health Sciences, McMaster University

ORCID: 0000-0002-2088-008X

Observed ORCID: 0000-0002-2088-008X

OpenAlex ID: A5046987520

The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis

2016 · Darryl P. Leong, François Caron, et al. · Blood · 233

PDF

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

2023 · Srdan Verstovsek, Aaron T Gerds, et al. · The Lancet · 202

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis

2016 · Chatree Chai-Adisaksopha, Christopher Hillis, et al. · Thrombosis and Haemostasis · 190

Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials

2015 · C. Chai‐Adisaksopha, C. Hillis, et al. · Journal of Thrombosis and Haemostasis · 190

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

2018 · K. Legault, H. Schunemann, et al. · Journal of Thrombosis and Haemostasis · 143

Strategies for eliciting and synthesizing evidence for guidelines in rare diseases

2019 · Menaka Pai, Cindy H. T. Yeung, et al. · BMC Medical Research Methodology · 98

PDF

Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding

2015 · Chatree Chai-Adisaksopha, Christopher Hillis, et al. · Thrombosis and Haemostasis · 98

Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis

2017 · François Caron, Darryl P. Leong, et al. · Blood Advances · 97

PDF

Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis

2015 · Chatree Chai-Adisaksopha, Wilson Lam, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 93

Investigation and management of erythrocytosis

2020 · Siraj Mithoowani, Marissa Laureano, et al. · Canadian Medical Association Journal · 90

PDF

Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review

2015 · C. Chai‐Adisaksopha, C. Hillis, et al. · Journal of Thrombosis and Haemostasis · 70

Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis

2019 · D. Little, C. Chai-Adisaksopha, et al. · Thrombosis Research · 64

Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia

2017 · Derek K. Chu, Christopher M. Hillis, et al. · Annals of Internal Medicine · 54

Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation

2021 · Maude Sestier, Christopher Hillis, et al. · Current Oncology Reports · 49

PDF

Gender and BCR ‐ ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia

2015 · Han‐Xin Lin, Jenny Sjaarda, et al. · European Journal Of Haematology · 45

Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis

2019 · Michelle P. Zeller, Bram Rochwerg, et al. · Vox Sanguinis · 38

Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis

2017 · Chatree Chai-Adisaksopha, Alfonso Iorio, et al. · Thrombosis Research · 38

Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants

2015 · Christopher M. Hillis, Mark A. Crowther · Thrombosis and Haemostasis · 34

Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group

2020 · Vikas Gupta, Sonia Cerquozzi, et al. · JCO Oncology Practice · 33

A systematic review of definitions and reporting of bleeding outcome measures in haemophilia

2015 · C. Chai‐Adisaksopha, C. Hillis, et al. · Haemophilia · 33

Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review

2018 · Deborah M. Siegal, Neal Manning, et al. · Journal of Intensive Care Medicine · 30

The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments

2015 · Christopher M. Hillis, Aaron D. Schimmer, et al. · Annals of Hematology · 22

Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease

2021 · Darryl Leong, Nazanin Aghel, et al. · Heart · 19

Diagnosis and management of iron deficiency in females

2025 · Michelle Sholzberg, Christopher Hillis, et al. · Canadian Medical Association Journal · 17

PDF

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study

2024 · James T. England, Natasha Szuber, et al. · Leukemia · 16

Works count: 103

Citation count: 2,224

H-index: 22

I10-index: 34